Euro Diagnostica EURIA Glucagon launched in Japan

May 6, 2013 - Company News, Product News, Disease Area News
Euro Diagnostica is pleased to announce that our product EURIA Glucagon has been launched in Japan in collaboration with our distribution partner Sceti Medical Labo KK. EURIA Glucagon is the only IVD approved Glucagon radioimmunoassay (RIA) in Japan and will be used by leading laboratories in the country.

EURIA Glucagon is specific for pancreatic glucagon with no cross-reactivity with gut GLI (Glucagon-Like-Immunoreactivity). The sensitivity of the assay, judged as 2 SD change from zero calibrator, is 3 pmol/L.

Background RIA - Radioimmunoassay

Radioimmunoassay (RIA) was first introduced in 1960 when hormone levels in the blood for the first time could be detected by an In Vitro assay. Due to the superior sensitivity of RIA, the technique continues to be widely used for accurate determination of small molecules, large molecules, peptides and proteins in biological samples.

Euro Diagnostica RIA Portfolio

Euro Diagnostica offers a portfolio of in-house developed RIA kits of high quality, manufactured in our own production facilities. Focus areas of our RIA products are:

-      Endocrine markers

-      Tumor markers

-      Metabolic markers

-      Vasoregulation

Further information regarding our RIA products is available via:

Euro Diagnostica RIA portfolio

« Back